KMPB vs TECH · rev $4.64B vs P/E 65, rev $1.22B
Kemper Corporation 5.875% Fixed (KMPB) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Kemper Corporation 5.875% Fixed (KMPB) common stock listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported KMPB revenue for 2024-12-31 was $4.64B. Net income was $312.5M. Revenue was down 6.2% from 2023-12-31 to 2024-12-31. KMPB currently screens at market cap $0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
KMPB currently screens at market cap $0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the KMPB and TECH stock pages for the full models.
Not investment advice.